Gina Consylman, Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 1,358 shares at $11.81 ($16K) on 2018-11-09, disclosed to the SEC on 2018-11-13.
Scheduled sale ($16k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IRWD | SELL | 2020-02-25 | $217K | — | Filing → |
| IRWD | SELL | 2019-11-12 | $17K | — | Filing → |
| IRWD | SELL | 2019-08-20 | $2K | — | Filing → |